Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
106.91
-1.46 (-1.35%)
May 29, 2026, 4:00 PM EDT - Market closed
Insmed Stock Forecast
Stock Price Forecast
According to 22 analysts polled by S&P Global, Insmed stock has a consensus rating of "Strong Buy" and an average price target of $200. The average 1-year stock price forecast is 87.07% higher than the current stock price, while the lowest is $140 (+30.95%) and the highest is $243 (+127.29%).
Price Target: $200 (+87.07%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Insmed stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 17 | 18 | 17 | 17 | 17 | 17 |
| Buy | 1 | 2 | 2 | 3 | 4 | 5 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 21 | 20 | 20 | 21 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $243 | Buy | Maintains | $243 | +127.29% | May 20, 2026 |
Unknown Analyst J.P. Morgan No rating | J.P. Morgan | Buy Maintains $180 | Buy | Maintains | $180 | +68.37% | May 20, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $185 | Buy | Maintains | $185 | +73.04% | May 19, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 18, 2026 |
| UBS | UBS | Buy Maintains $166 | Buy | Maintains | $166 | +55.27% | May 18, 2026 |
Financial Forecast
Revenue This Year
1.76B
from 606.42M
Increased by 190.06%
Revenue Next Year
2.87B
from 1.76B
Increased by 62.99%
EPS This Year
-2.77
from -6.42
EPS Next Year
0.57
from -2.77
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 2.3B | 3.5B | ||||||
| Avg | 1.8B | 2.9B | ||||||
| Low | 1.6B | 2.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 282.2% | 97.0% | ||||||
| Avg | 190.1% | 63.0% | ||||||
| Low | 160.0% | 22.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -1.96 | 1.72 | ||||||
| Avg | -2.77 | 0.57 | ||||||
| Low | -4.20 | -0.37 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.